Smart Innovation
Antimicrobial resistance (AMR)
AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights
For Researchers and Entrepreneurs who wish to investigate, develop and commercialize novel vaccines, diagnostics and antimicrobials to prevent Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities.
AMR Insights is for:
- Researchers at Universities and University Medical Centers
- Researchers at Research Institutes
- R&D professionals in Pharma, Biopharma and Diagnostics companies
- Entrepreneurs in start-up’s and spin off companies
- Innovators, Venture Capitalists.
Latest Topics
-
12 January 2026Antimicrobial resistance databases: opportunities and challenges for public health
The article reviews the role of antimicrobial resistance (AMR) databases in modern public health, explaining that these curated repositories of resistance genes and mutations enable the identification of AMR determinants from pathogen genomic data and support prediction of resistance profiles, thereby enhancing surveillance, outbreak response, infection prevention, diagnostic development, and tailored clinical decision-making. It compares […]
Read more... -
12 January 2026EMBL–EBI’s AMR portal: a new gateway in global antimicrobial resistance research
Antimicrobial resistance (AMR) is one of the world’s most serious health threats, with WHO estimating that around one in six common bacterial infections globally no longer responds to standard antibiotics—especially in low- and middle-income countries with limited laboratory capacity. To address critical data gaps in surveillance and diagnostics, European Molecular Biology Laboratory–European Bioinformatics Institute launched […]
Read more... -
09 January 2026New antimicrobial substances to combat increasing resistance
Antimicrobial resistance (AMR) represents a major and escalating global health threat, with an estimated 4.71 million deaths associated with AMR in 2021 and 1.14 million directly attributable to infections caused by multidrug-resistant organisms, particularly multidrug-resistant Gram-negative bacteria such as resistant Enterobacterales, Pseudomonas aeruginosa, and carbapenem-resistant Acinetobacter baumannii, which the World Health Organization identifies as priority […]
Read more...
More news related to Smart innovation
